Alzheimers Support

Introduction to Digital Identity in Government

Digital identity in the government sector refers to the electronic representation of an individual's identity, used to access public services securely and efficiently. As governments worldwide embrace digital transformation, digital identities enable seamless interactions between citizens and government agencies. They serve as a secure, verified digital profile that simplifies access to services such as tax filing, healthcare, social welfare, and voting. Implementing digital identities enhances transparency, reduces fraud, and improves service delivery. Moreover, they support the move toward paperless governance, fostering a more inclusive and accessible public sector. This shift aims to build trust, streamline administrative processes, and promote digital literacy among citizens. Overall, digital identity is a cornerstone of modern e-governance, helping governments become more responsive and accountable.

Benefits of Digital Identity for Governments

Digital identities offer numerous advantages for governments aiming to improve public service efficiency. They enable quick, secure authentication, minimizing…

I'm somewhat new here. My mother has later stage Alz. Can anyone recommend memory care or assisted living communities in the San Antonio area? Thanks.

Just following up on the discussion from the meeting. Here is the link from the Alz Association. https://www.medicalert.org/alzheimers-dementia

For those that already have the bracelets, a couple questions:

-How did your loved one react to wearing the bracelet?

-If they resisted, how did you get them to agree?

-Benefits of the medical alert bracelet vs alternative?

In 2017 Phil participated in a 7-month clinical drug study (SUVN-502) aimed at Alzheimer's patients in the moderate stage. In June, 2017 he barely qualified.

This was a double blind study. The meds were one of the following: placebo, 50 mg, or 100 mg of the research medicine. The object was to improve cognition.

This month the study was closed and unblinded. Phil was on the 50 mg dose. He had no negative side effects and he also showed no improvement. Other patients saw improvement, but some side effects.

Phase 3 is opening up, but not in any San Antonio locations.

Dr. Thomas Weiss, the psychiatrist who ran the study, in his effort to continue to study Alzheimer's Disease, has now moved to Clinical Trials of Texas. This company conducts Phase 4 studies on many diseases, including AD. At their website you can sign up for a free memory screening.